83 Recruiting Glioma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Glioma
Related Conditions
Top Recruiting Glioma Studies
Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
📍 University of California, Los Angeles — Los Angeles, California
View Study & Checklist ➔Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors
📍 Sunnybrook Health Sciences Centre — Toronto, Ontario
View Study & Checklist ➔Assessing Brain Metabolism Using MRS With Deuterated Glucose
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
📍 Children's Hospital of Orange County - Orange — Orange, California
View Study & Checklist ➔rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas
📍 UAB — Birmingham, Alabama
View Study & Checklist ➔Navigating the Clinical Research Process for Glioma
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔Residual IDH1-Mutant Tumor Cell Quantification Study
📍 NYU Langone Health — New York, New York
View Study & Checklist ➔A Study for Cerebral Open Flow Microperfusion
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔Movie-Watching Functional MRI for Mapping Brain Function in Neurosurgical Patients
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Language Network Prehab Via fMRI Neurofeedback
📍 Yale School of Medicine — New Haven, Connecticut
View Study & Checklist ➔All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
📍 Rosy Njonkou Tchoquessi — Baltimore, Maryland
View Study & Checklist ➔Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of 177Lu-PSMA-617 in People With Gliomas
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
📍 Northshore University Hospital — Manhasset, New York
View Study & Checklist ➔LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
📍 Maryland Proton Treatment Center — Baltimore, Maryland
View Study & Checklist ➔Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
📍 The Cancer Therapy and Research Center at UTHSCSA — San Antonio, Texas
View Study & Checklist ➔Tumor Treating Fields for the Treatment of Brainstem Gliomas
📍 Emory Proton Therapy Center — Atlanta, Georgia
View Study & Checklist ➔PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial
📍 Lynn Cancer Institute at Baptist Health, Inc. — Boca Raton, Florida
View Study & Checklist ➔Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
📍 Lenox Hill Brain Tumor Center — New York, New York
View Study & Checklist ➔Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
📍 Mayo Clinic in Florida — Jacksonville, Florida
View Study & Checklist ➔Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
📍 Hartford Healthcare Alliance (Data Collection Only) — Hartford, Connecticut
View Study & Checklist ➔PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma
📍 University of Rochester — Rochester, New York
View Study & Checklist ➔SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
📍 University of Alabama — Birmingham, Alabama
View Study & Checklist ➔Glioma Developmental and HyperActive Ras Tumor (DHART) Board
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔Registering Genomics and Imaging of Tumors (ReGIT)
📍 Indiana University School of Medicine — Indianapolis, Indiana
View Study & Checklist ➔